ENCORSTAT Trademark

Trademark Overview


On Wednesday, June 24, 2009, a trademark application was filed for ENCORSTAT with the United States Patent and Trademark Office. The USPTO has given the ENCORSTAT trademark a serial number of 77767425. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2019. This trademark is owned by Oxford BioMedica Plc. The ENCORSTAT trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Enzymes for scientific and research purposes in connection with treatment of the eye; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories in connection with treatment for the eye; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research in connection with treatment for the eye; chemical reagents for use in medical science

Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment of diseases of the eye, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations in connection with the treatment of diseases of the eye

Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances in connection with the treatment of diseases of the eye; syringes and injectors for medical purposes in connection with the treatment of diseases of the eye

Scientific and medical research and development in connection with the treatment of diseases of the eye; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology in connection with the treatment of diseases of the eye; advisory services relating to research and development of gene therapy products all in connection with the treatment of diseases of the eye and specifically excluding analysis services
encorstat

General Information


Serial Number77767425
Word MarkENCORSTAT
Filing DateWednesday, June 24, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2019
Registration Number4200422
Registration DateTuesday, September 4, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2011

Trademark Statements


Certificate of Correction for RegistrationIn the statement, Page 2, Column 1, line 12,"12-9-2009" should be deleted, and 12-3-2009 should be inserted.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesEnzymes for scientific and research purposes in connection with treatment of the eye; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories in connection with treatment for the eye; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research in connection with treatment for the eye; chemical reagents for use in medical science
Goods and ServicesGene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment of diseases of the eye, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations in connection with the treatment of diseases of the eye
Goods and ServicesMedical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances in connection with the treatment of diseases of the eye; syringes and injectors for medical purposes in connection with the treatment of diseases of the eye
Goods and ServicesScientific and medical research and development in connection with the treatment of diseases of the eye; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology in connection with the treatment of diseases of the eye; advisory services relating to research and development of gene therapy products all in connection with the treatment of diseases of the eye and specifically excluding analysis services
Pseudo MarkENCORE STAT

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxford BioMedica Plc
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressOxford OX4 6LT
GB

Party NameOxford BioMedica Plc
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressOxford OX4 4GA
GB

Party NameOxford BioMedica Plc
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressOxford OX44GA
GB

Trademark Events


Event DateEvent Description
Friday, April 5, 2019CANCELLED SEC. 8 (6-YR)
Friday, June 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 4, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 14, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 14, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 26, 2012CORRECTION UNDER SECTION 7 ¿ PROCESSED
Saturday, September 22, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 17, 2012TEAS SECTION 7 REQUEST RECEIVED
Tuesday, September 4, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 20121(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, July 20, 2012NOTICE OF ALLOWANCE CANCELLED
Friday, July 20, 2012TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, February 22, 2012CORRECTED NOA E-MAILED
Tuesday, February 21, 2012NOTICE OF ALLOWANCE CORRECTION ENTERED
Thursday, February 16, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 25, 2012FAX RECEIVED
Tuesday, January 24, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 21, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 19, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 18, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 18, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 11, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 18, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2011NON-FINAL ACTION E-MAILED
Wednesday, May 18, 2011NON-FINAL ACTION WRITTEN
Friday, April 29, 2011LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, October 22, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 7, 2010ASSIGNED TO LIE
Wednesday, April 7, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 7, 2010LETTER OF SUSPENSION E-MAILED
Wednesday, April 7, 2010SUSPENSION LETTER WRITTEN
Thursday, March 18, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 17, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 17, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 23, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2009NON-FINAL ACTION E-MAILED
Wednesday, September 23, 2009NON-FINAL ACTION WRITTEN
Tuesday, September 22, 2009ASSIGNED TO EXAMINER
Tuesday, June 30, 2009NOTICE OF PSEUDO MARK MAILED
Monday, June 29, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 27, 2009NEW APPLICATION ENTERED IN TRAM